MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
Chuanqing Jing,1,* Rong Fu,1,* Can Wang,2 Xiurong Li,3 Wei Zhang4 1The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, People’s Republic of China; 2Shandong University of Traditional Chinese Medicine, Jinan, People’s Republic of China; 3D...
Main Authors: | Jing CQ, Fu R, Wang C, Li XR, Zhang W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/mrpl13-act-as-a-novel-therapeutic-target-and-could-promote-cell-prolif-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer
by: Tao Z, et al.
Published: (2020-11-01) -
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway
by: Cai M, et al.
Published: (2021-02-01) -
Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
by: Yangyang Zeng, et al.
Published: (2021-05-01) -
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
by: Haoya Xu, et al.
Published: (2021-06-01) -
ING2 Controls Mitochondrial Respiration via Modulating MRPL12 Ubiquitination in Renal Tubular Epithelial Cells
by: Ying Yang, et al.
Published: (2021-08-01)